Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasm Metastasis 10Carcinoma, Non-Small-Cell Lung 10Breast Neoplasms 9Lung Neoplasms 5Prostatic Neoplasms 4Pancreatic Neoplasms 4Neoplasms 4Leukemia, Myeloid, Acute 4Colorectal Neoplasms 4Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Melanoma 3Leukemia 3Glioblastoma 3Cholangiocarcinoma 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Recurrence 2Gliosarcoma 2Glioma 2Congenital Abnormalities 2Colonic Neoplasms 2Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Thrombocythemia, Essential 1Stomatitis 1Primary Myelofibrosis 1Polycythemia Vera 1Pleural Effusion, Malignant 1Pain 1

Interventions

Carboplatin 11Pemetrexed 8Paclitaxel 8Radiotherapy 7Docetaxel 7Bevacizumab 7Cisplatin 6Gemcitabine 5pembrolizumab 3Taxes 3Metformin 3Vinorelbine 2Thalidomide 2Radiotherapy, Conformal 2Nivolumab 2Cetuximab 2trametinib 1sintilimab 1satraplatin 1ribociclib 1pegfilgrastim 1naporafenib 1motexafin gadolinium 1milademetan 1cixutumumab 1atezolizumab 1anetumab ravtansine 1aldesleukin 1Watchful Waiting 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Adenocarcinoma of Lung × Drug Therapy × Clear all
NCT02621333 2021-05-12

Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma

Henan Cancer Hospital

Phase 2 Terminated
280 enrolled
Thoracic

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡